From tumors and neurodegenerative diseases to cardiovascular diseases and inflammatory diseases, PARP members function as “molecular keys” that regulate the cellular microenvironment, thus facilitating precise diagnosis and targeted therapy. This evidence concerns the gene PARP1 and neurodegenerative disease.